ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

Weinstein Applauds Investigation Report

September 26, 1997

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

Breast Cancer Coalition to Congress: ‘Find a Way To Fund The War,’ Bypass Level Is Not Enough

August 7, 1992

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995